Clinical Trials Directory

Trials / Sponsors / Sirion Therapeutics, Inc.

Sirion Therapeutics, Inc.

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
Inflammation
Phase 32008-01-01
CompletedStudy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
Inflammation
Phase 32007-12-01
CompletedStudy of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degenerati
Geographic Atrophy, Dry Age Related Macular Degeneration
Phase 22006-12-01
CompletedStudy of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
Inflammation
Phase 32004-04-01
CompletedStudy of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Inflammation
Phase 22003-04-01
CompletedStudy of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Anterior Uveitis, Panuveitis
Phase 32002-08-01
CompletedStudy of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
Uveitis, Panuveitis
Phase 32002-08-01
CompletedStudy of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Anterior Uveitis
Phase 22000-03-01
CompletedStudy of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Inflammation
Phase 21999-12-01
CompletedStudy of Difluprednate in the Treatment of Uveitis
Uveitis
Phase 3—
CompletedStudy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
Inflammation
Phase 3—
CompletedStudy of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
Dry Eye Syndromes
Phase 3—
CompletedStudy of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
Dry Eye Syndromes
Phase 3—
CompletedStudy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)
Inflammation
Phase 3—
CompletedStudy of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
Dry Eye Syndromes
Phase 3—